BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37991763)

  • 1. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer.
    Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
    JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
    Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
    JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma.
    Deng L; Groman A; Jiang C; Perimbeti S; Gabriel E; Kukar M; Mukherjee S
    JAMA Netw Open; 2021 Nov; 4(11):e2135340. PubMed ID: 34797369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
    Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
    JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
    Kyalwazi B; Yau C; Campbell MJ; Yoshimatsu TF; Chien AJ; Wallace AM; Forero-Torres A; Pusztai L; Ellis ED; Albain KS; Blaes AH; Haley BB; Boughey JC; Elias AD; Clark AS; Isaacs CJ; Nanda R; Han HS; Yung RL; Tripathy D; Edmiston KK; Viscusi RK; Northfelt DW; Khan QJ; Asare SM; Wilson A; Hirst GL; Lu R; Symmans WF; Yee D; DeMichele AM; van 't Veer LJ; Esserman LJ; Olopade OI
    JAMA Netw Open; 2023 Dec; 6(12):e2349646. PubMed ID: 38153734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declination of Treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With Breast Cancer.
    Freeman JQ; Li JL; Fisher SG; Yao KA; David SP; Huo D
    JAMA Netw Open; 2024 May; 7(5):e249449. PubMed ID: 38722630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.
    Lipsyc-Sharf M; Ballman KV; Campbell JD; Muss HB; Perez EA; Shulman LN; Carey LA; Partridge AH; Warner ET
    JAMA Netw Open; 2023 Oct; 6(10):e2339584. PubMed ID: 37878313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
    Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
    JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
    Sung H; Wiese D; Jatoi I; Jemal A
    JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival.
    Heller DR; Nicolson NG; Ahuja N; Khan S; Kunstman JW
    JAMA Surg; 2020 Feb; 155(2):e195047. PubMed ID: 31800002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity.
    Wu SP; Keshavjee SH; Yoon SS; Kwon S
    JAMA Netw Open; 2023 Dec; 6(12):e2349026. PubMed ID: 38127346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.
    Woriax HE; Thomas SM; Plichta JK; Rosenberger LH; Botty van den Bruele A; Chiba A; Hwang ES; DiNome ML
    J Clin Oncol; 2024 May; 42(14):1635-1645. PubMed ID: 38394476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
    Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
    JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer.
    Zhao F; Miyashita M; Hattori M; Yoshimatsu T; Howard F; Kaneva K; Jones R; Bell JSK; Fleming GF; Jaskowiak N; Nanda R; Zheng Y; Huo D; Olopade OI
    JAMA Netw Open; 2023 Mar; 6(3):e233329. PubMed ID: 36995716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
    Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
    JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database.
    Peiffer DS; Zhao F; Chen N; Hahn OM; Nanda R; Olopade OI; Huo D; Howard FM
    JAMA Oncol; 2023 Apr; 9(4):500-510. PubMed ID: 36821125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
    Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
    JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.